Grey Wolf Animal Health CorpTSXV:WOLF
- LAST PRICE0.9400
- TODAY'S CHANGE (%)0.0500 (5.6180%)
- Bid / Lots0.9300/ 5
- Ask / Lots0.9500/ 10
- Open / Previous Close0.9200 / 0.8900
- Day Range
- 52 Week Range
- Volume10,610
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | WOLF |
|---|---|---|
| 09:32 ET | 500 | 0.92 |
| 09:42 ET | 5000 | 0.93 |
| 10:11 ET | 2500 | 0.92 |
| 01:13 ET | 2500 | 0.94 |
Nov 21, 2024
Press Release: GREY WOLF ANIMAL HEALTH REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS, from 5:00PM ET on Thursday Nov 21, 2024 by Dow Jones
5:00PM ET on Thursday Nov 21, 2024 by Dow JonesGREY WOLF ANIMAL HEALTH REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS, from 5:00PM ET on Thursday Nov 21, 2024 by Dow Jones
5:00PM ET on Thursday Nov 21, 2024 by Dow Jones
Oct 29, 2024
GREY WOLF ANIMAL HEALTH ANNOUNCES LAUNCH OF SILEO, from 5:00PM ET on Tuesday Oct 29, 2024 by Dow Jones
5:00PM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Grey Wolf Animal Health Corp | 29.2M | 89.8x | --- |
Optimi Health Corp | 20.4M | -3.3x | --- |
Vibe Growth Corp | 2.3M | -0.2x | --- |
Delota Corp | 3.2M | -1.8x | --- |
Psyched Wellness Ltd | 7.1M | -1.3x | --- |
P2P Group Ltd | 5.0M | -19.1x | --- |
Company Information
Grey Wolf Animal Health Corp. is a Canadian diversified animal health company. The Company markets a portfolio of products that meets the unmet needs of veterinarians, clinics and pets. The Company operates two business units: Animal Health business unit and Pharmacy business unit. The Animal Health business unit focuses on sourcing, in-licensing, acquiring, and commercializing branded and generic pharmaceutical, nutraceutical, and consumable products for use in veterinary clinics across Canada. The Pharmacy business unit compounds pharmaceuticals, primarily for animal and human use, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animal product category includes pharmaceuticals, wound care, nutraceuticals and disposables. Its equine health products include SUCCEED Digestive Conditioning Program, SUCCEED Equine Fecal Blood Test and Equi-Tape.
Contact Information
- Headquarters
- 100 King St. W. Suite 6000, 1 First Canadian PlaceToronto, ON, Canada M5X 1E2
- Phone
- 416-481-2222
- Fax
- ---
Executives
- Chief Executive Officer, Secretary
- Angela Cechetto
- Founder, Director, Chief Veterinary Medical Officer
- Ian Sandler
- Chief Financial Officer
- Kevin Palmer
- Chief Commercial Officer
- Murray Roach
- Director
- Shawn Aspden
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $29.2M |
|---|---|
Revenue (TTM) | $25.4M |
Shares Outstanding | 31.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.01 |
Book Value | $0.81 |
P/E Ratio | 89.8x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | 16.6x |
Operating Margin | 5.22% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
